Simpirica Spine, Inc., a San Carlos, CA-based developer of minimally invasive, flexion-restricting stabilization devices for the spine, has closed a $22m Series C venture funding.
The round was led by new investor Norwest Venture Partners, with existing investors De Novo Ventures and U.S. Venture Partners (USVP).
The company intends to use the funds to support the European commercialization of its lead product, the CE marked LimiFlex Spinal Stabilization System, which is typically used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis, with or without degenerative spondylolisthesis.
The device is still limited to investigational use in the U.S.
Founded in 2006, Simpirica Spine developed and tested its technology over a period of many years with the help of clinical and biomechanical experts from around the world.